Growth momentum but guidance cuts signal caution on profitability
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Cut credit growth guidance 18-20%→14%; missed NIM 3.5%→3.22%, ROA 1.25%→1.07%; met GNPA <2.25% target.
Cautiously Optimistic
next 1–2 quarters
Neutral
multi-year
Bank delivered strong 10.6% YoY PAT growth on the back of credit momentum (23.7% advances YoY) and improving GNPA (2.23%), but cut FY27 credit growth guidance from 18-20% to 14%—a significant reset. NIM compressed to 3.22% vs 3.5% target; Q2 profits supported ₹25Cr TWO recovery + ₹92Cr treasury/insurance gains, masking core profitability pressure. Execution risk on deposit mix and CASA conversion remain key headwinds.
₹3728.8 Cr
Revenue · +13.2% YoY₹547.3 Cr
Reported PAT · +10.6% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Credit growth momentum with retail focus (23.7% advances YoY)
METAdvances YoY 23.7%; but FY27 credit growth guidance cut from 18-20% to 14%
PAT jumped 29% QoQ and double-digit YoY growth
METDelivered PAT YoY 10.6%, QoQ 28.7%; partly driven by ₹25Cr TWO recovery + ₹92Cr treasury/insurance gains
GNPA coming down, asset quality improving to decadal best
METGNPA 2.23% (vs 2.37% Q1); within <2.25% guidance but still above 2% target
NIM improvement expected from rate hikes and CASA repricing
OVERSTATEDQ2 NIM 3.22%, down from Q1 3.28% and target 3.5%; management admits compression
ROA improvement with 1.2% guidance achievable
OVERSTATEDQ2 ROA 1.07%, below guidance 1.25%+ from Q1; 1.2% guidance conservative/defensive tone
Earnings quality
What changed since the last call
Credit growth guidance downgrade
DowngradeQ1 guided 18-20% FY27 credit growth; Q2 revised to 14% plus. Retail focus maintained but overall pace slowing.
Deposit guidance upgraded
UpgradeReaffirmed 10% in Q1; raised to 12% in Q2 (deposits +16.3% YoY, growing faster than expected)
ROA guidance reset lower
DowngradeQ1 guided 1.25%+; Q2 achieved 1.07%, revised guidance to 1.20%. Management tone evasive; relies on one-off recoveries.
NIM outlook cautious
DowngradeQ1 NIM 3.28% target 3.5%; Q2 NIM 3.22%, compressed 6 bps QoQ. Management expects recovery from rate hikes but unclear on timeline.
The Q&A
Analysts pressed hard on ROA (Deepak Poddar), credit growth (Hatim B), NIM drivers (Shruti Agrawal), bulk deposits (Jai Prakash Mundhra). Management deflected ROA questions (Amitava said 'at least we will not lose the ratio'), withheld detailed NIM guidance ('do not want to mention a particular number'), and was evasive on bulk deposit rundown timing. Tone defensive; no hard commitments on profitability recovery metrics.
CASA conversion strategy — Yuvraj Choudhary, Anand Rathi
PartialSigning MOUs with multiple organizations for salary accounts, including state government. ~20 such MOUs expected this quarter; positive CASA inflows recorded in Q2.
Credit cost outlook — Yuvraj Choudhary, Anand Rathi
AnsweredDo not expect incremental credit cost. Current slippages under control; no reason to increase credit cost. ECL model being finalized; detail to be shared by December.
ROA guidance — Deepak Poddar, Sapphire Capital
DodgedNot a downgrade, just conservative. Recovery in written-off accounts and other income in pipeline. 'At least we will not lose the ratio.' Will hit 1.20% and could exceed it.
Credit growth guidance change — Hatim B, JM Financial
AnsweredTarget revised to 14% plus. Retail to remain 60%, corporate 40%. Next quarter will see more rate hikes, retail advances growth will continue.
NIM trajectory — Shruti Agrawal, Nomura
PartialDo not want to mention a particular NIM number. 25 bps repo improvement expected to help. Yield should improve; CASA inflow pressure easing; substantial NIM improvement expected next quarter.
Other income components — Amansingh Sahajsinghani, ICICI Securities
PartialTWO recovery strong pipeline (8-10 quarters of prior recovery pace). OTS scheme approval in progress; cross-selling and treasury income also improving. Not a one-off; ongoing structural improvements.
Bulk deposit rundown — Jai Prakash Mundhra, ICICI Securities
AnsweredBulk deposits ~₹3,000Cr high-cost outstanding. Will benefit accrue in Q3? Yes, definitely Q3 and Q4.
Employee cost trajectory — Gaurav Agrawal, Nine One Capital
AnsweredExpected to remain flat, maybe slight dip from Q1 to Q2. Q3–Q4 will see additions; cost back to current levels by FY28 but not rising further.
Guidance
Credit growth 14% plus for FY27 (revised from 18-20%)
MediumRetail 60%, corporate 40% split. Retail advances focus continuing; economic headwinds cited
NIM to improve from 3.22% (H1) toward 3.5% via rate hikes + CASA repricing
Low25 bps repo expected; no specific NIM target disclosed; management avoiding number guidance
₹1,000Cr equity capital raise + ₹500Cr debt capital raise planned
MediumTiming flexible, awaiting opportune window. Debt likely this quarter; equity dependent on market conditions
Risks the call surfaced
Profitability sustainability
High₹25Cr TWO recovery + ₹92Cr treasury/insurance/cross-sell gains comprised ~22% of Q2 operating income. Without these, core PAT growth weaker. Management targets 'substantial' pipeline but durability for FY28 uncertain.
Net Interest Margin compression
HighQ2 NIM 3.22%, down from Q1 3.28% and target 3.5%. CASA decline (7% vs 10% guidance) raised cost of deposits to 4.85%. Management attributes to repo rate hike cycle reversal and deposit mix, but visibility limited on recovery timing.
Credit growth deceleration
MediumCredit growth guidance cut from 18-20% to 14%, a 4-6 ppt reduction. Management cites conservative approach and focus on retail, but cut suggests macro headwinds or asset quality concerns. Advances at 23.7% YoY but guidance for full year lower.
Deposit mix deterioration
MediumCASA growth only 7% YTD vs 10% FY27 guidance. Bulk deposits ~₹3,000Cr at high cost still outstanding. Despite MOUs signed, CASA conversion remains uncertain. If CASA doesn't recover, NIM pressure will persist.
ROA guidance uncertainty
MediumROA guidance revised down from 1.25%+ to 1.20%; Q2 delivered 1.07%. Amitava said 'at least we will not lose the ratio,' a defensive statement. ROA recovery tied to one-off recoveries (TWO, OTS) and non-fund-based income (~30-40% improvement Q2). Structural ROA improvement unclear.
ECL implementation risk
LowECL implementation ongoing; management said detail to be shared in December. Potential credit cost headwind if ECL assessment is materially different from current provisioning; management withheld numbers.
Management
Score 5/10. Mixed. Management disclosed Q2 numbers clearly but avoided specific guidance on NIM ('do not want to mention a particular number'), ROA ('at least we will not lose the ratio'), and ECL impact ('not what I want to mention at the moment'). Evasiveness on key profitability drivers undermines credibility. Moderate. Delivered 10.6% YoY PAT growth but cut credit growth guidance (18-20% → 14%); missed NIM (3.5% target vs 3.22% delivered), ROA (1.25% vs 1.07%), and ROE (~16% vs 13.68%) targets from Q1. GNPA improvement (2.37% → 2.23%) is on track.
1 · Q3 FY27
Repo rate transmission to improve yields; high-cost deposit shedding complete
2 · Q3–Q4 FY27
OTS scheme recovery + written-off account pipeline (2-year runway substantial)
3 · H2 FY27
₹1,000Cr equity + ₹500Cr debt capital raise to fund growth
Execution risk on deposit mix and CASA conversion remain key headwinds.
J&K Bank Q2FY27: PAT +10.6% YoY (~6% adjusted) to ₹553cr as provisions normalise
PAT +10.59% YoY · revenue +13.23% · margins compressing
₹3,728.78 Cr
+13.23% YoY
₹552.7 Cr
+10.59% YoY
13.66%
-0.7pp YoY
₹5.02
J&K Bank's consolidated PAT (primary basis) rose 10.6% YoY to ₹552.7 Cr for Q2 FY27 (standalone: ₹546.4 Cr, also +10.6% YoY), against a 13.2% YoY rise in interest earned to ₹3,728.8 Cr. Profit jumped 28.7% QoQ from Q1 FY27's ₹425.3 Cr, but that sequential move overstates momentum — Q1 was itself a soft base (PAT had fallen ~11.5% YoY in that quarter) and this quarter carries a ₹28.9 Cr pre-tax prior-period gain. Stripping that one-off out, adjusted YoY PAT growth is closer to 6%, a steadier read than the reported number suggests.
Q2 FY-2027 vs prior quarters
Pre-provision operating profit grew a much stronger 26.7% YoY to ₹790.4 Cr, widening the operating margin to 21.2% of interest earned from 18.9% a year ago, as revenue growth outpaced interest and operating expenses. That operating strength did not fully flow to the bottom line: provisions swung from a ₹10.9 Cr net write-back in Q2 FY26 to a ₹72.3 Cr charge this quarter (₹83.1 Cr of it NPA-related), and the effective tax rate rose to 23.8% from 22.0%, compressing net margin to 13.5% of total income from 14.3% a year ago. A separate accounting-policy change on PSLC expense recognition (Note 18) added ₹37.5 Cr to half-year PAT — a second item flattering this half's numbers.
The stock went into the print at ₹136.83, down 6.2% over the past month of trading.
For context: revenue is at a 6-quarter high.
FY27 credit growth 18–20% (vs 12% guidance; retail to drive 55–60%); deposit growth 10% reaffirmed; NIM target 3.5% (Q1: 3.28%), ROA 1.25%+ (vs prior 1.37% guidance), ROE ~16%, Gross NPA <2.25% (Q1: 2.37%).
— This quarter: met
Balance-sheet growth outpaced management's own FY27 guidance: consolidated advances rose 24.8% YoY to ₹1,31,202 Cr against a guided 18–20%, and deposits grew 16.3% YoY to ₹1,76,776 Cr against a reaffirmed ~10% target — consistent with the bank's October 3 disclosure of 19.4% YoY provisional business growth to ₹3,10,347 Cr. Asset quality also met target, with gross NPA at 2.23% versus management's <2.25% FY27 ceiling (2.37% in Q1). Profitability lags the growth story: annualised standalone ROA was 1.07%, up from 0.87% in Q1 but still short of the 1.25%+ FY27 goal, and NIM — guided at 3.5% against Q1's 3.28% — is not separately disclosed in this filing. No reliable street consensus specific to this quarter could be confirmed; some web results referenced profit figures that could not be reconciled to this filing, so vsStreet is left unknown rather than guessed. Standalone and consolidated PAT growth are closely aligned (both +10.6% YoY), so there is no material basis divergence to flag. Separately, the bank completed the sale of its PNB MetLife stake for ₹120.1 Cr on October 16 and saw director Dr. Mandeep K Bhandari resign on October 13 — both after the September 30 quarter-end and outside this P&L.
W1
ROA trajectory toward management's 1.25%+ FY27 target (1.07% this quarter, up from 0.87% in Q1)
W2
NIM versus the 3.5% FY27 target — last disclosed at 3.28% in Q1 FY27, not separately reported this quarter
W3
Provisioning run-rate (₹72.3 Cr this quarter vs a ₹10.9 Cr write-back a year ago) as the loan book scales 24.8% YoY
Reviewed (not audited); consolidated PAT ₹552.70cr includes ₹5.40cr share of associate profit (PBT−tax=₹547.30cr before that); Note 34 prior-period FVTPL investment-revaluation gain of ₹28.88cr sits in other income this quarter (one-off, excluded from adjusted YoY); Note 18 PSLC accounting-policy change lifted H1 PAT by ₹37.53cr; provisions swung from a ₹10.93cr net write-back (Q2 FY26) to a ₹72.35cr charge; ~₹0.2cr rounding in consolidated expenditure reconciliation; standalone and consolidated growth stories are closely aligned.
Loan Growth Plays Offence While Margins Face Deposit Mix Headwind
J&K Bank's 24% advance surge outpaces 16% deposit growth, signalling strong market share grab but NIM compression risk. Street sees upside to ₹218, but watch credit costs and CASA stabilization on result day.
The Setup: Growth vs Margin Squeeze
J&K Bank faces a classic PSU banking trade-off in Q2 FY27: aggressive advance growth is outpacing deposit mobilisation, lifting volumes but squeezing net interest margins. As of September 30, 2026, gross advances surged 23.72% YoY to ₹133,551 Cr, while total deposits grew only 16.29% to ₹176,796 Cr. More telling: CASA deposits (the cheap funding base) slipped to 42.01% of the mix, down 388 basis points year-over-year. This funding profile — lower CASA, higher-cost term deposits funding growth — is the critical lens for Q2 earnings. Investors cheering the growth momentum must also price the NIM headwind it brings.
~₹133,551 Cr
Up 23.72% YoY; up 6.8% sequentially from ₹124,981 Cr (Mar 31, 2026)
~₹176,796 Cr
Up 16.29% YoY; up 7.0% QoQ from ₹165,354 Cr. CASA ratio 42.01% (–388 bps YoY)
~₹310,347 Cr
Advances + deposits, up 19.38% YoY. Provisional and subject to audit.
What Strong vs Weak Q2 Looks Like
Strong Q2: Net profit growth matches or exceeds the ~19% run-rate despite NIM headwinds, thanks to tight credit costs and operating leverage on higher advances. Guidance for FY27 credit growth reaffirmed at 20%+, and management signals stabilization of CASA mix. Stock rallies on earnings beats and Street's 26% upside thesis. Weak Q2: NII growth lags advance growth (reflecting severe NIM compression beyond expectations), credit costs rise unexpectedly, or CASA deteriorates further. Net profit flatlines or declines, forcing Street to cut FY27 guidance. Stock re-tests support near ₹130, given it is already oversold (RSI 29.4).
On Track for Full Year?
J&K Bank is tracking strong asset-side momentum — Sep 30 operational data shows advance growth well above historical baselines and deposit mobilisation steady, even if mix is shifting. FY26 provided no published guidance in our records, so full-year FY27 assumptions remain user-specific. However, the bank's 24% advance growth in H1 FY27 (implied by Sep 30 data vs Mar 31, 2026) suggests the business is expanding faster than peers; the Street's BUY consensus and maintained target of ₹218 signal confidence that credit costs and asset quality will not derail profitability. Watch the credit cost numbers and slippage ratios on Oct 22 — they will determine whether growth is sustainable or funding-driven risk-taking.
Since Last Quarter: The Filing Scan
Recent corporate actions and disclosures since FY26 Q4 results:
Oct 13, 2026
Dr. Mandeep K Bhandari (IAS, Non-Exec Non-Indep) resigned effective Oct 13 due to official engagements.
Director resignation
Oct 12, 2026
Board will convene Oct 22 to consider and approve Unaudited Financial Results (Consolidated & Standalone) for Q2 FY27.
Board meeting notice
Oct 3, 2026
Total business ₹310,347 Cr (deposits + advances), up 19.38% YoY as of Sep 30, 2026. Provisional, subject to audit.
Provisional business figures
Sep 24, 2026
Tsewang Tharchin (IA&AS) appointed as Rotational Director at 88th AGM (Sep 22).
Director regularization
Sep 23, 2026
Designated persons' trading window closed from Oct 1, 2026 (pre-result blackout).
Trading window closure
Sep 22, 2026
Shareholder meeting held; Director retirements and new appointments approved. Revised Integrated Annual Report for FY26 released.
88th AGM held
Sep 21, 2026
Escrow Agreement signed for MetLife share sale transaction (JK Bank is selling/managing stake).
PNB MetLife share sale
Aug 31, 2026
Two General Managers retired due to age superannuation: Rakesh Koul and Syed Rais Maqbool.
GM retirements
Aug 20, 2026
Ashish Kundra (IAS, Non-Exec Non-Indep) resigned effective Aug 20 due to official engagements.
Director resignation
Summary: Board composition undergoing typical PSU rotational churn (two IAS director exits, two new appointments). The PNB MetLife share sale is administrative; no material earnings impact flagged. Insider trading window closure (Oct 1 onward) is routine pre-result protocol. No red flags operationally, but governance transitions always warrant attention.
What to Watch on Result Day (Oct 22)
1 · Net Interest Margin (NIM)
The headline question. Given CASA down 388 bps YoY and advances growing 24%, expect NIM compression. The Street needs to see NIM holding above 3.40–3.50% range (vs Q2 FY26's 3.56%). If NIM falls below 3.30%, it signals deposit funnel stress and will pressure FY27 earnings guidance.
2 · Net Interest Income (NII) and Net Profit growth
Watch whether NII growth exceeds advance growth in % terms (which would mean better pricing or fee traction offsetting NIM pressure). Net profit guidance for FY27 is critical — Street is pricing in mid-teen growth, but NIM compression could limit profit growth. Any cut to FY27 guidance will trigger a sell-off.
3 · Credit costs and slippage ratios
With such aggressive advance growth, credit costs must not deteriorate significantly. Watch Q2 FY27 gross slippage and provisioning ratios vs Q2 FY26. Any uptick in NPA formation will raise questions about underwriting standards in the growth push.
4 · CASA stabilization and deposit guidance
Can management commit to stabilizing or improving CASA mix in H2 FY27? Or do they concede another 100+ bps decline? This will shape NIM trajectory and deposit franchise valuation for the year.
5 · FY27 credit growth and advances guidance
Reaffirm 20%+ guidance or temper it? At 23.72% YoY through Sep 30, the bank is running hot. Management's stance on growth pace will signal confidence in funding and credit quality.
J&K Bank's Q2 FY27 earnings reflect a bank in offence mode: 24% advance growth signals market share grabs and confident credit underwriting, but 16% deposit growth and CASA ratio collapse raise the NIM trade-off question. Street sentiment is bullish (BUY consensus, ₹218 target, 26% upside), and at ₹137.45 the stock is oversold (RSI 29.4). But valuation re-rating hinges on proof that growth can coexist with acceptable margin compression. Watch NIM, profit guidance, and credit metrics on Oct 22 — they will determine if the near-32% discount to all-time high is a buying opportunity or a warning sign of earnings headwinds ahead. For now, the setup is classic PSU growth play with execution risk baked in.
Credit momentum, profitability mirage, and the guidance cuts that matter
J&K Bank's ₹547 Cr Q2 profit jumped 28.7% QoQ, but ₹117 Cr in one-off gains — recoveries and treasury income — inflated the bottom line. The real story: management cut guidance across credit, ROA, and NIM, and missed every profitability target set last quarter.
₹547 Cr
+10.6% YoY
₹117 Cr
TWO ₹25 Cr + treasury ₹92 Cr
~₹430 Cr
~21% of PAT from one-offs
Low single digit
vs 10.6% reported
The headline masks the reality
J&K Bank's bottom line looks respectable on the surface — ₹547 Cr PAT, up 28.7% quarter-on-quarter and 10.6% year-on-year. But peel back the layers, and ₹117 crore of that profit came from one-time items: a ₹25 crore recovery from the TWO (debt waiver) scheme and ₹92 crore in treasury, insurance, and cross-selling gains. Remove those, and adjusted PAT shrinks to roughly ₹430 crore — a low-single-digit organic gain. The market should be asking whether that adjusted number is sustainable.
At least we will not lose the ratio. I mean we are able to achieve it. And maybe I said 1.20 plus. So it will be definitely more than 14%.
That quote — 'at least we will not lose the ratio' — tells you everything about management's conviction on profitability recovery. Not bullish. Not confident. Defensive. And for good reason.
What held up, what didn't
Credit growth momentum with retail focus (23.7% advances YoY)
PAT jumped 29% QoQ on strong underlying profit growth
Asset quality improving to decadal best (GNPA 2.23%)
NIM to improve from rate hikes and CASA repricing
ROA recovery to 1.25%+ achievable in H2
The credit story is real — advances grew 23.7% YoY, with retail driving over 60% of incremental advances. GNPA fell 14 basis points quarter-on-quarter to 2.23%, and asset quality is genuinely improving. But profitability tells a different story. The 28.7% QoQ jump in PAT is almost entirely due to the ₹117 crore in one-offs. Strip those out, and the organic quarter is pedestrian. More troubling: management cut guidance across every major metric.
The guidance cuts that define the quarter
That credit guidance cut is the headline. Management went from 18–20% FY27 growth to 14%. Yes, they claim "conservative," but cutting a 2,000+ basis point range is not conservatism — it signals execution challenges or macro caution. Simultaneously, they missed the NIM target (3.22% vs 3.5%), lowered ROA expectations (1.07% delivered, 1.25%+ promised), and missed ROE by 250 basis points. The only thing that went their way was deposits, which grew 16.3% YoY and are now guiding to 12% for the full year.
Why NIM won't snap back as quickly as management hopes
Management's NIM story hinges on CASA repricing and rate cycle tailwinds. But the numbers tell a messier story. CASA deposits grew only 7% year-to-date against a 10% FY27 target. Meanwhile, the bank still carries ~₹3,000 crore in high-cost bulk deposits, pushing the cost of deposits up to 4.85% in Q2. The bank is signing MOUs to convert deposits to CASA, but conversion risk is real. Without CASA momentum, NIM stays under pressure even as rates move higher. Management's vague language on NIM recovery — "do not want to mention a particular number" — suggests they don't have high conviction on the timing.
The bull case
Advances growth at 23.7% is genuine strength, with retail, agriculture, and MSME all firing. GNPA has fallen to 2.23% and is within the bank's guidance of <2.25%, marking real asset quality improvement. Operating costs are under control (cost-to-income at 56.57%, better sequentially and YoY). The capital adequacy ratio sits at 16.57% with a CET1 of 13.88%, providing ample headroom for growth. And FII/DII ownership is slowly rising — FII added 104 basis points quarter-on-quarter to 9.38%, and DII added 184 basis points to 7.84%, suggesting some institutional confidence in the recovery story.
The bear case
The bank's profitability recovery is contingent on one-off recoveries. ₹25 crore from TWO and ₹92 crore from treasury/insurance/cross-sell represent 21% of operating income in Q2. Management claims durability ('2-year runway' for recoveries; 'not a one-off'), but without hard numbers on the pipeline, the claim is hollow. Core PAT growth is anemic. Credit growth guidance was slashed by 4–6 percentage points. NIM is below target and compressed 6 basis points quarter-on-quarter despite rate hikes. ROA guidance was lowered, and management was evasive about how to achieve even 1.20%. The stock is down 38.58% from its all-time high of ₹201.75, suggesting the market is skeptical of the recovery narrative.
How the street is positioned
Price action: The stock closed at ₹123.91, sitting below its 20-day SMA (₹135.26), 50-day SMA (₹142.96), and 200-day SMA (₹136.15). RSI of 36.9 signals neither oversold nor overbought — neutral, with a slight bearish lean. Trading volume is increasing, which could indicate either capitulation selling or accumulation; the price action suggests the former is more likely, as every rally below the 200-day SMA has been met with selling.
Valuation context: The 38.58% drawdown from the all-time high puts the stock 27.28% above its 52-week low. It's a beaten-down stock, but one that hasn't stabilized yet. The technical setup suggests there's no near-term relief; institutions are not crowding in to catch the falling knife.
Ownership trends: FII ownership rose 104 basis points to 9.38% in Q1 FY27, and DII ownership rose 184 basis points to 7.84%. This is slow accumulation, not a rout. Promoter holding remains steady at 59.40%. The fact that foreign and domestic institutions are inching higher suggests some of them see a bottom-fishing opportunity, but the pace is cautious — they're not putting serious capital to work yet.
Ranked risks: what should concern a holder
Profitability sustainability / one-off dependency
High₹117 Cr of the ₹547 Cr PAT (21%) came from recoveries and treasury gains. Without these, organic growth is low-single-digit. Management's pipeline claim has no quantum attached; investors are betting on narrative, not numbers.
NIM compression amid CASA deterioration
HighNIM fell to 3.22% vs 3.5% target, and CASA is growing only 7% vs 10% target. Cost of deposits at 4.85% is sticky. Rate hike tailwinds are real, but timing is uncertain, and CASA conversion is execution-risk-laden.
Credit growth deceleration
MediumGuidance cut from 18–20% to 14% is a significant reset. While Q2 advances grew 23.7% YoY, full-year guidance lower suggests macro headwinds or management is playing it safe to avoid missing again.
ROA recovery evasiveness
MediumQ2 ROA of 1.07% is below the 1.25%+ guidance from Q1, and the new 1.20% target was described as 'conservative.' Management was vague on how to get there; seems contingent on one-off recovery pipeline.
Deposit mix deterioration
MediumBulk deposits of ~₹3,000 Cr at high cost remain outstanding. CASA growth lagging suggests deposit repricing (upward) continues; shedding bulk deposits is planned for Q3–Q4, but execution risk remains.
ECL implementation risk
LowManagement disclosed detail by December 2026. Potential credit cost headwind if ECL assessment differs materially from current provisioning. Management withheld detail, suggesting they don't want to commit to a number yet.
What to watch next quarter
1 · Adjusted PAT (ex one-offs)
Is organic profit accelerating, or does it flatten without recoveries? If Q3 one-off income drops materially, the market will know core growth is weak.
2 · CASA conversion progress
Did the 20+ MOUs signed in Q2 convert to actual deposits? If CASA growth stays at 7%, NIM pressure will persist into H2. Watch the CASA ratio and cost of deposits.
3 · Bulk deposit rundown
Management promised Q3–Q4 shedding of the ~₹3,000 Cr high-cost deposits. Monitor the quantum shed and the NIM benefit. If rundown doesn't happen, NIM guidance for FY28 is at risk.
4 · Real credit growth pace
Q2 advances grew 23.7% YoY, but FY27 guidance is 14%. Is the slowdown already happening, or is it concentrated in H2? Watch the quarterly pace to validate the new guidance.
5 · ECL implementation disclosure
By December, management will finalize the ECL model and reveal the base figure. If it triggers higher provisioning, credit cost will rise and ROA guidance will be at risk.
The debate
The verdict
Hold
Execution risk on profitability too high
6 / 10
Management tone defensive; one-off dependency real
Adjusted PAT
Watch organic growth ex one-offs
J&K Bank's Q2 was a steady quarter masked by one-time gains. Credit growth is real, asset quality is improving, and capital is adequate for expansion. But the bank's profitability story is contingent on recoveries that management claims are durable but won't quantify, and on NIM and ROA recovery that management is evasive about achieving. The guidance cuts — credit from 18–20% to 14%, ROA from 1.25%+ to 1.20%, NIM target missed — signal that management is in retreat mode, not growth mode. The stock's 38% drawdown from the all-time high reflects that reality. For a value investor, the current price is not yet compelling; the risk-reward is balanced at best. The bank needs to deliver on adjusted profitability in Q3 and show real progress on CASA and bulk deposit rundown. Until then, Hold is the right call.
The quarter tells a story of momentum in credit growth, improvement in asset quality, and softness in profitability. The market has priced in the softness with a 38% decline from the all-time high. FII/DII are inching in, suggesting some see opportunity, but the pace is slow — the street is not convinced that profitability recovery is imminent. The honest read is that J&K Bank is executing steadily on credit and credit quality, but profitability is not a step-change; it's a grind, and one that depends heavily on recoveries rather than structural improvement. The number to track from here is adjusted PAT — the organic growth the bank can deliver without leaning on one-offs. If that number stays in low-single-digit growth, the bear case takes hold. If it accelerates to double-digits, the bull case reopens. Q3 will tell.